“I Love What You Are Doing for Patients Just Like Me”
Jon Coe, Co-founder and CEO of Prescient Surgical, shares on a patient's ordeal with SSI and how patient stories like these give meaning to his entrepreneurial journey.
In the News
News & Blog
Rubbing Salt in the Wound
CleanCision was inspired by patients. This post shares the experience of Steve Benjamin, avid heli skier cyclist, and sportsman, who survived a difficult bowel resection surgery for cancer, only to contract a surgical site infection, causing serious complications that changed his life.
Blog
Reducing the Risk of Surgical Infections: An Interview with the Co-Founders of Prescient Surgical
CleanCision's journey from the Stanford Biodesign prototyping lab with surgeons to commercial use -- to protect patients from surgical site infection.
In the News
CleanCision Shown to Significantly Reduce High Surgical Site Infection Rates in Colorectal Surgery as Compared to Standard Wound Protectors
New data show that the CleanCision™ System, a novel, advanced irrigating wound protection therapy, was shown to reduce high rates of surgical site infection (SSI) by 100% as compared to a standard wound protector control group after 30-day follow up.
Press Releases
Making the Switch from Engineer to CEO
A podcast with UCSF Rosenman Institute reveals how Jonathan Coe makes the switch from Engineer to CEO at Prescient Surgical.
In the News
The Need for Tall Poppies
Healthcare Risk expert Russ Nassof shares his views on effectuating change in healthcare, calling for an urgent need for “Tall Poppies” to advance evidence-based medicine.
Blog
Advancing Tomorrow in the Operating Room of Today
Prescient Surgical CEO Jonathan Coe shares advice for surgeons committed to pursuing tomorrow’s innovations in today’s changing healthcare landscape
Blog
Novel Irrigating Wound Retractors Shown to Be Cost Effective in Colorectal Surgery
Novel Irrigating Wound Retractors Shown to Be Cost Effective in Colorectal Surgery. Journal of Surgical Research published study shows that reductions in surgical site infection (SSI) lead to substantial cost savings for hospitals
Press Releases
Prescient Surgical Raises $10 Million in Series B Investment
Baxter Ventures leads round to accelerate availability of CleanCision, first-in-class, advanced therapy for surgical patients that fights and defends against the sources of surgical site infection
Press Releases
The Solution to Pollution is Dilution
Dr. Charles Edmiston shares highlights from his article in Surgical Infections on intraoperative wound irrigation -- a "standard of practice" without a standard
Blog